Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry.

Parks BA, Shearer JD, Baudys J, Kalb SR, Sanford DC, Pirkle JL, Barr JR.

Anal Chem. 2011 Dec 1;83(23):9047-53. doi: 10.1021/ac201910q. Epub 2011 Nov 4.

PMID:
22017298
2.

Inhalational botulism in rhesus macaques exposed to botulinum neurotoxin complex serotypes A1 and B1.

Sanford DC, Barnewall RE, Vassar ML, Niemuth N, Metcalfe K, House RV, Henderson I, Shearer JD.

Clin Vaccine Immunol. 2010 Sep;17(9):1293-304. doi: 10.1128/CVI.00080-10. Epub 2010 Jul 21.

3.

Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.

Kalb SR, Lou J, Garcia-Rodriguez C, Geren IN, Smith TJ, Moura H, Marks JD, Smith LA, Pirkle JL, Barr JR.

PLoS One. 2009;4(4):e5355. doi: 10.1371/journal.pone.0005355. Epub 2009 Apr 28.

4.

From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry.

Boyer AE, Moura H, Woolfitt AR, Kalb SR, McWilliams LG, Pavlopoulos A, Schmidt JG, Ashley DL, Barr JR.

Anal Chem. 2005 Jul 1;77(13):3916-24.

PMID:
15987092
5.

Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.

Wang D, Baudys J, Ye Y, Rees JC, Barr JR, Pirkle JL, Kalb SR.

Anal Biochem. 2013 Jan 15;432(2):115-23. doi: 10.1016/j.ab.2012.09.021. Epub 2012 Sep 24.

6.

Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.

Kalb SR, Garcia-Rodriguez C, Lou J, Baudys J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR.

PLoS One. 2010 Aug 17;5(8):e12237. doi: 10.1371/journal.pone.0012237.

7.

Improved detection of botulinum neurotoxin type A in stool by mass spectrometry.

Wang D, Baudys J, Kalb SR, Barr JR.

Anal Biochem. 2011 May 1;412(1):67-73. doi: 10.1016/j.ab.2011.01.025. Epub 2011 Jan 26.

PMID:
21276417
8.

Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates.

Wang D, Krilich J, Baudys J, Barr JR, Kalb SR.

Bioorg Med Chem. 2015 Jul 1;23(13):3667-73. doi: 10.1016/j.bmc.2015.04.012. Epub 2015 Apr 10.

9.

The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples.

Kalb SR, Moura H, Boyer AE, McWilliams LG, Pirkle JL, Barr JR.

Anal Biochem. 2006 Apr 1;351(1):84-92. Epub 2006 Feb 3.

PMID:
16500606
10.

Botulinum neurotoxin detection and differentiation by mass spectrometry.

Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, McWilliams LG, Schmidt JG, Martinez RA, Ashley DL.

Emerg Infect Dis. 2005 Oct;11(10):1578-83.

11.

Multiplex detection of microbial and plant toxins by immunoaffinity enrichment and matrix-assisted laser desorption/ionization mass spectrometry.

Kull S, Pauly D, Störmann B, Kirchner S, Stämmler M, Dorner MB, Lasch P, Naumann D, Dorner BG.

Anal Chem. 2010 Apr 1;82(7):2916-24. doi: 10.1021/ac902909r.

PMID:
20199054
12.

Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic Activity.

Kalb SR, Boyer AE, Barr JR.

Toxins (Basel). 2015 Aug 31;7(9):3497-511. doi: 10.3390/toxins7093497. Review.

13.

Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples.

Kalb SR, Baudys J, Wang D, Barr JR.

Toxins (Basel). 2015 May 19;7(5):1765-78. doi: 10.3390/toxins7051765.

14.

A two-stage multiplex method for quantitative analysis of botulinum neurotoxins type A, B, E, and F by MALDI-TOF mass spectrometry.

Wang D, Baudys J, Krilich J, Smith TJ, Barr JR, Kalb SR.

Anal Chem. 2014 Nov 4;86(21):10847-54. doi: 10.1021/ac502948v. Epub 2014 Oct 20.

15.

Direct biosensor detection of botulinum neurotoxin endopeptidase activity in sera from patients with type A botulism.

Lévêque C, Ferracci G, Maulet Y, Mazuet C, Popoff M, Seagar M, El Far O.

Biosens Bioelectron. 2014 Jul 15;57:207-12. doi: 10.1016/j.bios.2014.02.015. Epub 2014 Feb 18.

16.

Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.

Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR.

BMC Biochem. 2011 Nov 15;12:58. doi: 10.1186/1471-2091-12-58.

17.

A new peptide substrate for enhanced botulinum neurotoxin type B detection by endopeptidase-liquid chromatography-tandem mass spectrometry/multiple reaction monitoring assay.

Rosen O, Feldberg L, Gura S, Zichel R.

Anal Biochem. 2015 Mar 15;473:7-10. doi: 10.1016/j.ab.2014.09.016. Epub 2014 Sep 30.

PMID:
25277815
18.

Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics.

Kalb SR, Goodnough MC, Malizio CJ, Pirkle JL, Barr JR.

Anal Chem. 2005 Oct 1;77(19):6140-6.

PMID:
16194071
19.

Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.

Dunning FM, Ruge DR, Piazza TM, Stanker LH, Zeytin FN, Tucker WC.

Appl Environ Microbiol. 2012 Nov;78(21):7687-97. doi: 10.1128/AEM.01664-12. Epub 2012 Aug 24.

20.

A label-free biosensor assay for botulinum neurotoxin B in food and human serum.

Ferracci G, Marconi S, Mazuet C, Jover E, Blanchard MP, Seagar M, Popoff M, Lévêque C.

Anal Biochem. 2011 Mar 15;410(2):281-8. doi: 10.1016/j.ab.2010.11.045. Epub 2010 Dec 4.

PMID:
21134347

Supplemental Content

Support Center